Stock DNA
Agricultural Commodities/Milling
CAD 2 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.03
22.60%
-0.01
Revenue and Profits:
Net Sales:
10 Million
(Quarterly Results - Sep 2024)
Net Profit:
-8 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-50.0%
0%
-50.0%
6 Months
-50.0%
0%
-50.0%
1 Year
-50.0%
0%
-50.0%
2 Years
-80.0%
0%
-80.0%
3 Years
-94.12%
0%
-94.12%
4 Years
-98.53%
0%
-98.53%
5 Years
-98.73%
0%
-98.73%
Entourage Health Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.91%
EBIT Growth (5y)
8.49%
EBIT to Interest (avg)
-4.36
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.03
Sales to Capital Employed (avg)
2.05
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.23%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.01
EV to EBIT
-13.69
EV to EBITDA
-14.37
EV to Capital Employed
32.77
EV to Sales
4.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-239.42%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.23%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ
Sep'24
Jun'24
Change(%)
Net Sales
9.50
9.30
2.15%
Operating Profit (PBDIT) excl Other Income
-1.00
-3.40
70.59%
Interest
7.10
6.80
4.41%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-8.40
-10.30
18.45%
Operating Profit Margin (Excl OI)
-122.30%
-380.50%
25.82%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2024 is 2.15% vs -26.77% in Jun 2024
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2024 is 18.45% vs -63.49% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
40.70
40.90
-0.49%
Operating Profit (PBDIT) excl Other Income
-19.30
-41.10
53.04%
Interest
24.40
17.50
39.43%
Exceptional Items
-3.70
-58.60
93.69%
Consolidate Net Profit
-46.20
-123.10
62.47%
Operating Profit Margin (Excl OI)
-482.50%
-1,148.90%
66.64%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -0.49% vs -3.31% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 62.47% vs -56.02% in Dec 2022
About Entourage Health Corp. 
Entourage Health Corp.
Agricultural Commodities/Milling
WeedMD Inc. is a Canada-based company, which supplies a range of cannabis and cannabis-related products. The Company is a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) and operates an approximately 26,000 square foot production facility in Aylmer, Ontario. Its products include: Dried Cannabis, Cannabis Extracts and Cannabis Vaporizes. The Company provides healthcare providers and their patients with the information they need to comprehend the role medical cannabis can play in their pain-management regimen and enable them to make informed decisions regarding their overall health. In addition, the Company participates in ongoing cannabis research.






